Veer Bhavnagri's most recent trade in Allogene Therapeutics Inc was a trade of 23,628 Common Stock done at an average price of $5.7 . Disclosure was reported to the exchange on March 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. | 14 Mar 2023 | 23,628 | 556,049 (0%) | 0% | 5.7 | 133,971 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 13 Feb 2023 | 3,000 | 577,677 (0%) | 0% | 6.9 | 20,550 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 7.04 per share. | 17 Jan 2023 | 3,000 | 580,677 (0%) | 0% | 7.0 | 21,120 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 7.53 per share. | 15 Dec 2022 | 5,602 | 583,677 (0%) | 0% | 7.5 | 42,186 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 272,435 | 272,435 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 175,438 | 589,279 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 7.68 per share. | 15 Mar 2022 | 8,849 | 413,841 (0%) | 0% | 7.7 | 67,962 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 5,000 | 112,300 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 24.77 per share. | 15 Sep 2021 | 5,000 | 421,669 (0%) | 0% | 24.8 | 123,845 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 15 Sep 2021 | 5,000 | 426,669 (0%) | 0% | 2.3 | 11,350 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 16 Aug 2021 | 5,000 | 421,353 (0%) | 0% | 21.0 | 104,994 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 5,000 | 117,300 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 16 Aug 2021 | 5,000 | 426,353 (0%) | 0% | 2.3 | 11,350 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 21.55 per share. | 15 Jul 2021 | 5,000 | 421,353 (0%) | 0% | 21.6 | 107,753 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2021 | 5,000 | 122,300 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 15 Jul 2021 | 5,000 | 426,353 (0%) | 0% | 2.3 | 11,350 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 25.32 per share. | 15 Jun 2021 | 5,000 | 421,353 (0%) | 0% | 25.3 | 126,600 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 5,000 | 127,300 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 15 Jun 2021 | 5,000 | 426,353 (0%) | 0% | 2.3 | 11,350 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 18 May 2021 | 5,000 | 426,353 (0%) | 0% | 2.3 | 11,350 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 18 May 2021 | 5,000 | 421,353 (0%) | 0% | 30 | 150,000 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 5,000 | 132,300 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2021 | 5,000 | 137,300 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 17 May 2021 | 5,000 | 426,353 (0%) | 0% | 2.3 | 11,350 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 28.30 per share. | 17 May 2021 | 5,000 | 421,353 (0%) | 0% | 28.3 | 141,476 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 15 Apr 2021 | 10,000 | 431,353 (0%) | 0% | 2.3 | 22,700 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2021 | 10,000 | 142,300 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 32.01 per share. | 15 Apr 2021 | 9,394 | 421,959 (0%) | 0% | 32.0 | 300,738 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 32.64 per share. | 15 Apr 2021 | 606 | 421,353 (0%) | 0% | 32.6 | 19,780 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 82,469 | 82,469 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 22,202 | 421,353 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 15 Mar 2021 | 10,000 | 415,774 (0%) | 0% | 2.3 | 22,700 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 10,000 | 152,300 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 37.79 per share. | 15 Mar 2021 | 9,600 | 399,551 (0%) | 0% | 37.8 | 362,808 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 38.16 per share. | 15 Mar 2021 | 6,623 | 409,151 (0%) | 0% | 38.2 | 252,730 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 38.15 per share. | 15 Mar 2021 | 400 | 399,151 (0%) | 0% | 38.2 | 15,260 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2020 | 51,500 | 162,300 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 17 Dec 2020 | 51,500 | 405,402 (0%) | 0% | 2.3 | 116,905 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Oct 2020 | 10,000 | 213,800 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 06 Oct 2020 | 10,000 | 353,902 (0%) | 0% | 40 | 400,000 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 06 Oct 2020 | 10,000 | 363,902 (0%) | 0% | 2.3 | 22,700 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 25,000 | 223,800 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.27 per share. | 01 Oct 2020 | 25,000 | 378,902 (0%) | 0% | 2.3 | 56,750 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 36.21 per share. | 01 Oct 2020 | 16,215 | 362,687 (0%) | 0% | 36.2 | 587,069 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 37.03 per share. | 01 Oct 2020 | 7,985 | 354,702 (0%) | 0% | 37.0 | 295,664 | Common Stock |
| Allogene Therapeutics Inc | Veer Bhavnagri | General Counsel | Sale of securities on an exchange or to another person at price $ 37.72 per share. | 01 Oct 2020 | 800 | 353,902 (0%) | 0% | 37.7 | 30,180 | Common Stock |